Clinical Research Division, Fred Hutch
Dr. Michael Wagner is a medical oncologist who specializes in treating patients with sarcoma. He studies the molecular drivers of bone and soft tissue sarcomas and leads clinical trials of immunotherapy treatments, including checkpoint inhibitors, for patients with this rare group of diseases.
University of Washington School of Medicine
B.S., Duke University
M.D., Harvard University
Residency, Internal Medicine, Mount Sinai Medical Center
Fellowship, Medical Oncology, MD Anderson Cancer Center
To understand the molecular drivers of sarcomas and to translate this knowledge to develop clinical trials, ultimately leading to new treatments for this rare group of diseases
Study Number: CITN-12B
Study Number: 20182222
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210